Advanced Practice Providers & Allied Healthcare Professionals - AUA Annual Meeting

advertisement

Advanced Practice Providers & Allied Healthcare Professionals

AUA2025 – Advanced Practice Providers & Allied Healthcare Professionals

The AUA is committed to providing quality, evidence-based urologic education to the entire urologic health care team! The AUA Annual Meeting features two full days of programming devoted to enhancing the education of advanced practice providers (APPs) and other allied healthcare professionals. The AUA has developed these programs based on the educational needs assessment of advanced practice providers working in urology. This program will be recorded and can be accessed on-demand.

This program is included in your AUA2025 registration and space is limited.

APP Programs You Won't Want to Miss!

Urologic Care for the Advanced Practice Provider

Saturday, April 26 – Sunday, April 27, 2025

Location
The Venetian Convention & Expo Center
Las Vegas, NV

AUA2025 is hosting two full days of programming focused on enriching the education of APPs and other allied healthcare professionals. Scheduled for Saturday, April 26, and Sunday, April 27, 2025, this program aims to benefit both novice and experienced urologic APPs by covering topics that are highly relevant to their practice. Topics will include AUA Guidelines, oncology, shared decision making, BPH, OAB, sexual health and more!


Additional AUA2025 Educational Offerings Relevant to APPs!

Outside of the 2-day program, AUA2025 offers further education to APPs! With a plethora of Instructional Courses and additional programming, Advanced Practice Providers and Allied Health Professionals can gain knowledgeable experience and skills in Las Vegas.

Check out the full listing of all that Annual Meeting has to offer APPs!


APP Networking Events

Join us for NON-CME Sponsored Meal Symposia taking place during our 2-day APP program!

Location
The Venetian Convention & Expo Center
Palazzo AB

Saturday, April 26, 2025
Breakfast Symposium
6:45 – 8 a.m.
Treatment of Overactive Bladder Symptoms in Males With Pharmacologically Treated Benign Prostatic Hyperplasia
Scott Young, PA & Morgan McDowell, NP
Supported by Sumitomo Pharma America, Inc.

Lunchtime Symposium
12:20 – 1:35 p.m.
A Review of Real-World Head-to-Head Data in Advanced Prostate Cancer
Chelsie Ferrell, PA & Caroline Branch, NP
Supported by Johnson & Johnson

Sunday, April 27, 2025
Breakfast Symposium
6:45 – 8 a.m.
Engaging APPs in an Efficient Urology Practice
Gregg Eure, MD, Janelle Bunce, PA-C, Jamie Giovanelli, PA-C
Supported by Teleflex Interventional Urology

Lunchtime Symposium
Noon – 1:15 p.m.
Treatment Intensification with XTANDI (Enzalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer & Nonmetastatic Castration-Sensitive Prostate Cancer with Biochemical Recurrence at High Risk for Metastasis
Vahan Kassabian, MD, FACS, FRCS
Supported by Astellas Pharma US and Pfizer Oncology